We are live on ! Find out more
RC

Roundview Capital Portfolio holdings

AUM $1.83B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+26.02%
3 Year Est. Return
+77.66%
5 Year Est. Return
+94.56%
10 Year Est. Return
+341.66%
AUM
$1.43B
AUM Growth
+$51.9M
Cap. Flow
+$44.3M
Cap. Flow %
3.09%
Top 10 Hldgs %
33.34%
Holding
348
New
10
Increased
187
Reduced
90
Closed
16

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.65M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.29M
3
KLAC icon
KLA
KLAC
+$1.21M
4
CSGP icon
CoStar Group
CSGP
+$1,000K
5
KBH icon
KB Home
KBH
+$882K

Sector Composition

Rank Sector Weight
1 Technology 16.76%
2 Financials 14.29%
3 Industrials 7.36%
4 Consumer Discretionary 7.29%
5 Communication Services 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLI icon
176
RLI Corp
RLI
$5.62B
$1.45M 0.1%
17,598
+7,942
+82% +$659K
UPS icon
177
United Parcel Service
UPS
$89.5B
$1.44M 0.1%
11,458
-521
-4% -$68.6K
NSC icon
178
Norfolk Southern
NSC
$75B
$1.44M 0.1%
6,131
+522
+9% +$133K
APG icon
179
APi Group
APG
$17B
$1.43M 0.1%
59,435
+734
+1% +$17.5K
SPMD icon
180
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
$1.41M 0.1%
25,873
+987
+4% +$55.5K
VEU icon
181
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
$1.4M 0.1%
24,306
+700
+3% +$42.2K
CSX icon
182
CSX Corp
CSX
$93B
$1.39M 0.1%
43,140
+80
+0.2% +$2.74K
EW icon
183
Edwards Lifesciences
EW
$50B
$1.38M 0.1%
18,581
-312
-2% -$21.8K
LH icon
184
Labcorp
LH
$25.9B
$1.36M 0.09%
5,917
+73
+1% +$16.7K
ULTA icon
185
Ulta Beauty
ULTA
$22.2B
$1.33M 0.09%
3,050
-629
-17% -$244K
CHD icon
186
Church & Dwight Co
CHD
$23.1B
$1.31M 0.09%
12,490
+315
+3% +$33.2K
BLK icon
187
Blackrock
BLK
$170B
$1.3M 0.09%
1,263
+64
+5% +$65K
TEVA icon
188
Teva Pharmaceuticals
TEVA
$41.2B
$1.29M 0.09%
58,709
+1,850
+3% +$33.7K
XOM icon
189
ExxonMobil
XOM
$651B
$1.29M 0.09%
12,001
+1,141
+11% +$133K
TRV icon
190
Travelers Companies
TRV
$78.4B
$1.27M 0.09%
5,292
ABT icon
191
Abbott
ABT
$183B
$1.27M 0.09%
11,253
+453
+4% +$52.3K
MAR icon
192
Marriott International
MAR
$99B
$1.27M 0.09%
4,537
-5
-0.1% -$1.37K
SHOP icon
193
Shopify
SHOP
$159B
$1.24M 0.09%
11,659
MEDP icon
194
Medpace
MEDP
$16.1B
$1.23M 0.09%
3,714
+87
+2% +$29.5K
EWJ icon
195
iShares MSCI Japan ETF
EWJ
$22.1B
$1.22M 0.09%
18,198
-1,775
-9% -$122K
BSCR icon
196
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$1.21M 0.08%
62,089
NEE icon
197
NextEra Energy
NEE
$183B
$1.2M 0.08%
16,733
+218
+1% +$16.9K
MUB icon
198
iShares National Muni Bond ETF
MUB
$45.2B
$1.19M 0.08%
11,211
TYL icon
199
Tyler Technologies
TYL
$13.3B
$1.17M 0.08%
2,031
IWR icon
200
iShares Russell Mid-Cap ETF
IWR
$56.1B
$1.16M 0.08%
13,158

Similar funds

Roundview Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Roundview Capital held 348 positions worth $1.43B, up 3.8% from $1.38B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Roundview Capital deployed $44.3M of net new capital in Q4 2024, opening 10 new positions and adding to 187 existing holdings. Its largest new stake was Invesco BulletShares 2028 Corporate Bond ETF: 45,661 shares worth $919K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Diageo, an estimated $750K trimmed.

  • Roundview Capital's largest Q4 2024 buy was Invesco BulletShares 2028 Corporate Bond ETF: 45,661 shares worth $919K.
  • Roundview Capital added most to Vanguard Morningstar Total Stock Market ETF in Q4 2024, an estimated $3.84M increase.
  • Roundview Capital's biggest Q4 2024 reduction was Diageo, cutting an estimated $750K.
  • Roundview Capital fully exited Idexx Laboratories in Q4 2024, selling an estimated $1.65M.
  • Roundview Capital's ten largest holdings make up 33% of its $1.43B portfolio in Q4 2024.
  • Roundview Capital opened 10 new positions and closed 16 in Q4 2024.
  • Roundview Capital's portfolio value rose 3.8% quarter-over-quarter to $1.43B.

Based on Roundview Capital's 13F filing for Q4 2024, filed 12 Feb 2025.